Navigation Links
Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
Date:8/21/2007

New research by scientists in Taiwan has shown that an 800-year-old formula, Four-Agents Decoction (Si Wu Tang), does not significantly reduce menstrual pain after three cycles of treatment; however, a beneficial effect may be present after a longer treatment. The dosage regimen and treatment length used in this study are not associated with adverse reactions. The results are published in the August 15 issue of the online, open-access journal PLoS ONE.

Four-Agents Decoction is composed of dry roots of four plants native to China: prepared Radix Rehmanniae praeparata (Soe Dee Huang), Radix Paeoniae Alba (Bai Sau), Radix Angelicae Sinensis (Dang Guay), and Rhizoma Ligustici Chuanxiong (Tsuan Chyong). This formula is originally listed in the Prescriptions of Peoples Welfare Pharmacy (in Chinese) as a remedy for nourishing the blood and has been used as a basic formula in traditional Chinese medicine for treating womens illnesses since the Song dynasty (twelfth century). Although many analgesics are available, this formula is worth studying, as non-specified dysmenorrhoea is still one of the most common gynecological complaints in young women worldwide.

The participants in the study were 78 primary dysmenorrheic women in the Taipei, Taiwan, metropolitan area. At the end of treatment, both menstrual overallpain- and peak-pain-intensity did not differ significantly between the Four-Agents-Decoction group and the placebo group. But statistically significant pain-reducing effect appeared in the first follow-up cycle.

We did not obtain clear evidence for our hypothesis that Four-Agents-Decoction had a beneficial effect to treat primary dysmenorrhoea says Dr. Lan Lan Liang Yeh, the studys principal investigator. But the unexpected result of a statistically significant pain-reducing effect in the first post-treatment cycle is intriguing and warrants a rigorous similar trial with a larger sample size, a longer treatment phase, and multiple batched study products in different populations to determine the definitive efficacy of this historically documented formula.


Disclaimer

The following press release refers to an article in PLoS ONE. The release has been provided by the article authors and/or their institutions. Any opinions expressed in this are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

The protocol underwent reviews by the National Health Research Institutes and the study received funding support from NHRI; the Department of Health, Taiwan; and the National Science and Technology Program for Biotechnology and Pharmaceuticals.

Notes for editors The government of Taiwan established the National Health Research Institutes in 1996. NHRI is a non-profit, autonomous research organization dedicated to the enhancement of medical research and the improvement of health care in Taiwan.

Contact: Pochuan Li

Public Affairs Office, National Health Research Institutes Tel: +886-2-37-246166 ext31500 Email: pochuan@nhri.org.tw

Citation: Yeh LLL, Liu J, Lin K, Liu Y, Chiou J, et al. (2007) A Randomised Placebo-Controlled Trial of a Traditional Chinese Herbal Formula in the Treatment of Primary Dysmenorrhoea. PLoS ONE 2(8): e719. doi:10.1371/journal.pone.0000719

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://www.plosone.org/doi/pone.0000719


'/>"/>
Contact: Pochuan Li
pochuan@nhri.org.tw
Public Library of Science
Source:Eurekalert

Related medicine news :

1. New target for antidiabetic agents identified
2. Gold Nanoparticles: Agents For Noninvasive Cancer Therapy
3. New Multi-Modal Contrast Agents, A Boon For Medical Imaging
4. Newer Contrast Agents Safe for Children
5. Less Allergic Reactions to Iodine-containing Contrast Agents in Children
6. Gene Therapy shows promise in treating Hemophilia
7. Treating Depression In Children Could Lead To Poor Bone Development
8. Treating Epilepsy With Surgery
9. Treating Autism More Effectively
10. Stem Cell Therapy Effective For Treating Heart Attacks
11. Treating Leukemia With Natural Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... McKinney, Texas (PRWEB) , ... February 24, 2017 , ... ... south to The Medical Center at Craig Ranch building at 8080 State Highway 121, ... Ranch Medical District with easy access to Highway 121. , As the practice has ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The California ... conference convening academic faculty engaged in or interested in palliative care education and research. ... will be held in North County San Diego on Sept. 28 and 29, 2017, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly ... Dyer started as the Chairman of the Management Committee when IFN was originally ... including the recruitment of investor/owners and development of the business plan. He became ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 The ... of the PhenoTest BC Kit, performed on the ... identify organisms that cause bloodstream infections and provide ... to respond to (antibiotic sensitivity). The test also ... provide this important information, which can guide antibiotic ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) ... Board of Directors that will be submitted to the ... representatives of the company,s three largest shareholders at the ... accepted a seat on the Nomination Committee, and the ... Nomination Committee was as follows:  ...
Breaking Medicine Technology: